Aurobindo Pharma reported 24.18 in PE Price to Earnings for its fiscal quarter ending in September of 2026.





Pe Change Date
Cipla 38.39 2.57 Sep/2026
Divis Laboratories Ltd 84.22 25.87 Sep/2026
Dr.Reddys Laboratories 35.92 2.77 Sep/2026
Hindustan Unilever 40.62 5.51 Sep/2026
Sun Pharmaceuticals 37.28 1.1 Sep/2026
UPL 22.66 1.39 Sep/2026